Siddharth Agarwal, M.B.B.S., is a physician who has worked in research and programming in public health, nutrition, maternal and newborn health, community empowerment, urban health planning, and policy support to national and state governments and global public health policy advocacy. He has been working for the cause of well-being, nutrition, and health of disadvantaged populations for 30 years. He is the director of Urban Health Resource Centre (UHRC), a nonprofit organization that works for the health, nutrition, and well-being of 500,000 disadvantaged urban dwellers through demonstration programs in partnership with slum communities and government departments, and it also engages in research, policy support, and advocacy. UHRC played a key role in stakeholder consultations, meetings, and study tours, and consolidating lessons from programs over 6 years for the government of India’s National Urban Health Mission that mandates reaching out to all listed and unlisted slums and vulnerable settlements. He has collaborated nationally and internationally with researchers of U.S. and UK universities and institutions on several projects dealing with urban well-being, health, and sustainable development. He teaches public health from a multidisciplinary perspective and is adjunct faculty at the Johns Hopkins Bloomberg School of Public Health and in the Department of Global Health at The George Washington University. He has served as guest faculty at the University of California, Berkeley; TERI University; Institut d’Études Politiques Sciences Po, Paris; Coady International Institute STFX–Canada; Touro College, New York; University of Leeds, United Kingdom; Delhi University, IIT–Kanpur; and Indian Institute of Public Health, Delhi. He has been guiding in-country and overseas Ph.D.
and master’s students for the past several years. He has been a member of several government of India committees, a member of several international committees and panels, and an advisor to the World Health Organization (South East Asia Regional Office and Kobe Centre, Japan), United Nations Human Settlement Program, United Nations Population Fund, and United Nations Children’s Fund, United Nations University, and the International Society for Urban Health on different aspects of vulnerability, disparities, health care, public health, community health, nutrition, urban health, well-being, policy, practice, and sustainable development. He is the past president of the International Society of Urban Health (2010–2011) and was an executive board member from 2008 to 2014. He is a member of editorial boards and review panels of several international journals and has been a reviewer for The Wellcome Trust, United Kingdom. He has had more than 100 articles, research papers, book chapters, and reports published in Indian and international journals, books, and newspapers. His interviews have been published by governmental and nongovernmental periodicals and newspapers and by international agencies. He is a recipient of an AXA Outlook Award, a nomination-based award of AXA Research Fund, Paris, and the Rotary Vocational Service Award for his services toward the betterment of the underprivileged in 2015. He delivered the Professor Shakuntala Memorial Oration at his alma mater, Lala Lajpat Rai Memorial Medical College, Meerut, at the start of the Medical College’s Golden Jubilee year activities in 2016.
Jason Corburn, Ph.D., M.C.P., is the director of the Institute of Urban and Regional Development and a professor in the Department of City and Regional Planning and the School of Public Health at the University of California, Berkeley. His research focuses on environmental justice and climate change in cities, the links between urban planning and public health, and inclusive community development for informal settlements in cities in Africa, Asia, and Latin America. He is a research and evaluation advisor for the World Health Organization, the International Council of Science, and numerous local and national governments. Dr. Corburn has conducted research projects on the health equity impacts of new urban governance strategies in San Francisco and Richmond; sanitation, food security, and community development projects in Nairobi’s informal settlements; and community planning, poverty reduction, and infectious disease in Rio de Janeiro and Salvador, Brazil. Dr. Corburn has received numerous awards, including the United Nations Association Global Citizenship Award, the Paul Davidoff Best Book Award, the Health Policy Investigator Award from the Robert Wood Johnson Foundation, and the Environmental Leadership Program Fellowship.
Maria Gloria Dominguez-Bello, Ph.D., received her undergraduate degree in 1983 from Simon Bolivar University, her master’s degree in 1987 (animal nutrition), and her Ph.D. in 1990 (microbiology) from the University of Aberdeen, Scotland. In 1993, she was a European Union Marie Curie postdoctoral fellow in the United Kingdom and France. She developed her scientific career to full professor at the Venezuelan Institute of Scientific Research, where she worked for 14 years, and at the University of Puerto Rico, where she worked for 11 years. Since 2012 she has been an associate professor of medicine at the New York University School of Medicine. She is a fellow of the American Academy of Microbiology and of the Infectious Diseases Society of America, and has served as a board member of Livestock Science, Microbial Ecology, Frontiers in Microbiology, Microbes and Infection, mBio, and Scientific Reports. Her lab integrates data from genomics/metagenomics, microbiology, ecology, physiology, and anthropology to address broad questions about microbe–host interaction, including development of the infant microbiota, effect of the Western lifestyle, and microbiota restoration.
Christopher Dye, FRS, FMedSci, is the director of strategy, policy, and information in the Office of the Director-General at the World Health Organization (WHO). Dr. Dye began professional life as an ecologist in the United Kingdom, having graduated from the University of York (B.A., biology) and the University of Oxford (D.Phil., zoology). After developing an interest in infectious diseases at Imperial College London, he moved to the London School of Hygiene & Tropical Medicine to bring his research closer to public health. He was head of the school’s Vector Biology and Epidemiology Unit until 1996, carrying out research on leishmaniasis, malaria, rabies, and other infectious and zoonotic diseases in Africa, Asia, and South America. In 1996, he joined WHO, where he has developed methods for using national surveillance and survey data to study the large-scale dynamics and control of tuberculosis, malaria, Ebola, Zika, and other communicable diseases. As director of strategy, he now serves as science advisor to the director-general and other senior staff, oversees the production and dissemination of health information via the WHO press and libraries, and coordinates WHO’s sustainable development network. From 2006 to 2009, he was also professor of physics (and other biological sciences) at Gresham College, and 35th in a lineage of professors that have been giving public lectures in the City of London since 1597. He is a fellow of The Royal Society (the UK National Academy of Sciences) and of the UK Academy of Medical Sciences. He is a visiting professor of zoology at the University of Oxford and a member of the Board of Reviewing Editors for Science.
Marcos A. Espinal, M.D., Dr.P.H., M.P.H., is the director of the Department of Communicable Diseases and Health Analysis at the Pan American Health Organization (PAHO), Regional Office of the World Health Organization (WHO) for the Americas. Dr. Espinal, a national of the Dominican Republic, holds a medical degree from the Universidad Autónoma de Santo Domingo, Dominican Republic (1985). He has an M.P.H. (1990) and a Dr.P.H. (1995) from the University of California, Berkeley, School of Public Health. His work experience includes positions in the Ministry of Health of the Dominican Republic and the National Center for Research on Maternal and Child Health; the New York City Public Health Department; and WHO, where he worked for 13 years. Before joining PAHO, Dr. Espinal served as the executive secretary of the WHO Stop TB Partnership, a global movement aiming to eliminate tuberculosis as a public health problem. Dr. Espinal has published more than 100 peer-reviewed publications in the field of communicable diseases. He is a recipient of the Scientific Prize of the International Union against Tuberculosis and Lung Diseases; the Walter and Elise A. Hass International Award by the University of California, Berkeley, for a distinguished record of service in international health; and the Princess Chichibu Memorial Tuberculosis Global Award by the Japan Anti-Tuberculosis Association.
Alex Ezeh, Ph.D., stepped down as the executive director of the African Population and Health Research Center (APHRC) on September 30, 2017, after 17 years. As the founding executive director, Dr. Ezeh guided APHRC to become one of Africa’s foremost regional research centers addressing population, health, education, and development issues. He initiated and directed the Consortium for Advanced Research Training in Africa, an initiative to strengthen doctoral training and the retention of academics at African universities. He was a member of The Rockefeller Foundation-Lancet Commission on Planetary Health and the Lancet Commission on the Future of Health in Africa. He currently co-chairs the Guttmacher-Lancet Commission on Sexual and Reproductive Health in a post-2015 world. Dr. Ezeh is honorary professor of public health at the University of the Witwatersrand, South Africa, and holds an honorary doctor of science degree from KCA University, Kenya, and a doctorate in demography from the University of Pennsylvania. He serves on the boards of several organizations, including the United Nations University–International Institute for Global Health (Kuala Lumpur), the World Health Organization’s Alliance for Health Policy and Systems Research (Geneva), and the International Initiative for Impact Evaluation (3ie).
Emily Gurley, Ph.D., M.P.H., is an associate scientist in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She leads multidisciplinary studies on the transmission and prevention of emerging and vaccine preventable diseases, such as Nipah virus, hepatitis E virus, and arboviruses. She has worked in Bangladesh for more than a decade, and her interests include improving the communication and collaboration between field epidemiologists and infectious disease modelers and development of novel surveillance strategies. Her research adopts a One Health approach to the study and prevention of infectious disease, taking into account the ecological context in which disease occurs. Dr. Gurley is the co-director for the Child Health and Mortality Prevention Surveillance site in Bangladesh, which aims to determine the etiology of and prevent child deaths. She also works closely with the U.S. Centers for Disease Control and Prevention’s Global Disease Detection program.
Eva Harris, Ph.D., is a professor in the Division of Infectious Diseases in the School of Public Health and the director of the Center for Global Public Health at the University of California, Berkeley. She has developed a multidisciplinary approach to study the molecular virology, pathogenesis, immunology, epidemiology, clinical aspects, and control of dengue, Zika, and chikungunya, the most prevalent mosquito-borne viral diseases in humans. Specifically, her work addresses immune correlates of protection and pathogenesis, viral and host factors that modulate disease severity, and virus replication and evolution using in vitro approaches, animal models, and research involving human populations. This has been possible through a close collaboration with the Ministry of Health in Nicaragua for more than 28 years. Her international work focuses on laboratory-based and epidemiological studies of dengue, chikungunya, Zika, and influenza in endemic Latin American countries, particularly in Nicaragua, where ongoing projects include clinical and biological studies of severe dengue; a pediatric cohort study of dengue, Zika, chikungunya, and influenza transmission in Managua; a household transmission study of Zika; and a recently concluded cluster randomized controlled trial of evidence-based, community-derived interventions for prevention of dengue via control of its mosquito vector. She is also directing a study of Zika in infants and pregnancy in Nicaragua and evaluating a number of Zika diagnostic tests with her team in Nicaragua. In 1997, she received a MacArthur Award for work over the previous 10 years developing programs to build scientific capacity in developing countries to address public health and infectious disease issues. This enabled her to found a nonprofit organization in 1998, Sustainable Sciences Institute (www.sustainablesciences.org), with offices in San Francisco, Nicaragua, and Egypt, to continue and expand this work.
Dr. Harris was named a Pew Scholar for her work on dengue pathogenesis. She received a national recognition award from the Minister of Health of Nicaragua for her contribution to scientific development and was selected as a “Global Leader for Tomorrow” by the World Economic Forum. In 2012, she was elected Councilor of the American Society of Tropical Medicine and Hygiene and received a Global Citizen Award from the United Nations Association. She has published more than 200 peer-reviewed articles, as well as a book on her international scientific work.
Albert Icksang Ko, M.D., an infectious disease physician, is a professor and the chair of the Department of Epidemiology of Microbial Diseases at the Yale School of Public Health and a collaborating researcher at the Oswaldo Cruz Foundation in the Brazilian Ministry of Health. His research centers on the health problems that have emerged as a consequence of rapid urbanization and social inequity. Dr. Ko coordinates a research and training program on urban slum health in Brazil and is conducting prospective studies on rat-borne leptospirosis, dengue, meningitis, and respiratory infections. His research particularly focuses on understanding the transmission dynamics and natural history of leptospirosis, which works as a model for an infectious disease that has emerged in slum environments due to the interaction of climate, urban ecology, and social marginalization. Current research combines multidisciplinary epidemiology, ecology, and translational research-based approaches to identify prevention and control strategies that can be implemented in slum communities. Dr. Ko is also the program director at Yale for the Fogarty Global Health Equity Scholars Program, which provides research training opportunities for U.S. and low- and middle-income country post- and predoctoral fellows at collaborating international sites. Since December 2016, the research and training program in the city of Salvador, Brazil, has mobilized its efforts to investigate the ongoing outbreak of Zika virus infection and microcephaly.
Daniele Lantagne, Ph.D., is an associate professor in civil and environmental engineering at Tufts University. She is a public health engineer (Massachusetts Institute of Technology [MIT], B.S., 1996; M.Eng., 2001; P.E., 2003) who received her Ph.D. in 2011 from the London School of Hygiene & Tropical Medicine. She began working in water, sanitation, and hygiene to reduce the burden of infectious disease while earning her master’s degree, and continued working in this field teaching in the Department of Civil and Environmental Engineering at MIT until she joined the U.S. Centers for Disease Control and Prevention in 2003. She completed her postdoctoral work at Harvard’s Center for International Development from 2010 to 2012, and joined Tufts University as a professor in 2012. Over the past 16 years, Dr. Lantagne provided technical assistance or
conducted research in more than 50 countries in Africa, Asia, and Central and South America in both development and emergency contexts. She has published more than 50 papers on water supply, water treatment, hygiene, and sanitation in developing countries and is a technical advisor to Potters for Peace, FilterPure, and charity: water. Her main research interest is how to reduce the burden of infectious diseases by investigating and evaluating the effectiveness of water and sanitation interventions. She runs an active group completing laboratory, field, and policy research and currently supervises one postdoctoral student and six Ph.D. and undergraduate researchers with funding from agency, government, nongovernmental organization, foundation, and private sources.
Yuguo Li, Ph.D., is a professor and the associate dean (research) of engineering and former head of the Department of Mechanical Engineering at the University of Hong Kong. He studied at Shanghai Jiaotong University, Tsinghua, and KTH Royal Institute of Technology in Stockholm, and was a principal research scientist at the Commonwealth Scientific and Industrial Research Organisation. His main research interests are on built environment engineering (indoor air quality, city climate, and environmental studies of infection). Recently his team received a collaborative research fund from the Hong Kong government to study how microbes are transmitted on the surface network and indoor contact network in a large city. He led the development of 2009 World Health Organization guidelines on natural ventilation. Professor Li currently serves as an associate editor of Indoor Air, and he is the president of the International Society of Indoor Air Quality (ISIAQ) Academy of Fellows. He received the John Rydberg Gold Medal from SCANVAC in 2014, an honorary doctor degree from Aalborg University, Denmark, in 2015, and the Inoue Memorial Award from the Society of Heating, Air-conditioning, and Sanitary Engineers, Japan, in 2016. He was elected a fellow of ISIAQ, as well as the American Society of Heating, Refrigerating, and Air-conditioning Engineers; the Hong Kong Institution of Engineers; and the Institution of Mechanical Engineers.
Steve Lindsay, Ph.D., is a public health entomologist with a passion for studying some of the world’s most important vector-borne diseases, including malaria, lymphatic filariasis, dengue, and trachoma. He has considerable experience in medical entomology, parasitology, ecology, and clinical epidemiology and solves pure and applied problems in the laboratory and field using a wide range of techniques from DNA fingerprinting and mathematical modeling to methods used by social scientists, epidemiologists, and biologists. His particular interest is in the design of simple tools for malaria control, and he has carried out field studies in Burkina Faso, China,
Ethiopia, Gambia, Kenya, Laos People’s Democratic Republic, Tanzania, Thailand, and Uganda over the past 30 years. He has published more than 200 peer-reviewed papers, many in major international journals. He was in one of the leading groups of researchers in the 1980s that demonstrated that insecticide-treated bed nets protected children against malaria. Since then he has helped develop and carry out field trials of topical repellents, larval source management, combinations of long-lasting insecticidal nets and indoor residual spraying, new resistance-busting mosquito nets, and house screening. He is an advocate for integrated vector management and the improvement of housing as a protection against vector-borne diseases. He has an honorary chair in public health entomology at the London School of Hygiene & Tropical Medicine, is a co-chair of the Vector-borne Diseases and the Built Environment work stream of Roll Back Malaria, and is a member of the World Health Organization’s Vector Control Advisory Group and Technical Advisory Group for Neglected Tropical Diseases. He is also the co-director of the Building Out Vector-borne diseases in Africa network (BOVA).
Frank Mahoney, M.D., is an infectious disease epidemiologist who is currently working for the Global Immunization Division (GID) at the U.S. Centers for Disease Control and Prevention (CDC). He is a graduate of the University of Texas Medical School in Houston and completed a residency in family medicine at Baylor University. He joined the CDC in 1989 as an Epidemic Intelligence Service officer and has worked on a variety of assignments throughout his career. He is currently seconded by GID to the International Federation of the Red Cross and Red Crescent Societies. In 2014–2015, he was the CDC team lead for Ebola response in Nigeria and Liberia. Prior to the Ebola outbreak, he was the CDC team lead for polio eradication in Nigeria. Between 2007 and 2011, he was head of the CDC office in Indonesia, and prior to that assignment, he worked for 10 years in the Middle East Region, including 4 years at the Eastern Mediterranean Regional Office (EMRO) of the World Health Organization and 6 years with the U.S. Naval Medical Research Unit No. 3 in Cairo. He is a member of the EMRO Technical Advisory Group on Immunization and the author of numerous scientific publications and book chapters. He is a member of the John Snow Society and an adjunct faculty member at the Emory University Rollins School of Public Health.
Eric Mintz, M.D., M.P.H., obtained his medical degree from the State University of New York in 1984, completed an internal medicine residency at Harlem Hospital in 1987, and received a master in public health from Columbia University in 1989. He joined the U.S. Centers for Disease Con-
trol and Prevention as an Epidemic Intelligence Service officer that year, where he has since worked on approaches to prevent waterborne and foodborne diseases in the Americas, Africa, and Asia. Dr. Mintz has authored or co-authored more than 170 scientific publications on topics including typhoid and paratyphoid fever, cholera, dysentery, and new technologies to make safe drinking water, safe sanitation, and better hygiene more accessible, affordable, and sustainable in developing countries.
Lee W. Riley, M.D., is a professor and the head of the Division of Infectious Disease and Vaccinology at the School of Public Health, University of California, Berkeley. He is a physician who has been trained in both epidemiology and molecular microbiology. Dr. Riley did his undergraduate studies at Stanford University, where he received a B.A. in philosophy. He went to medical school at the University of California, San Francisco, and completed a residency in internal medicine at Columbia-Presbyterian Hospital in New York. After residency, Dr. Riley joined the Epidemic Intelligence Service at the U.S. Centers for Disease Control and Prevention (CDC), and then became an infectious disease fellow at the Stanford University School of Medicine. After the fellowship, he joined the World Health Organization to work as a project manager for a program called India Biomedical Support Project in New Delhi, India, for 2 years. Dr. Riley became an assistant professor of medicine at the Cornell University Medical College in 1990, and transferred to the University of California, Berkeley, in 1996 as professor of infectious diseases. He currently directs a research training program called Global Health Equity Scholars program, a consortium of four institutions—University of California, Berkeley; Yale University; Stanford University; and Florida International University—which is funded by the National Institutes of Health’s Fogarty International Center, designed to provide training for U.S. and lower- and middle-income country postdoctoral fellows and scholars in slum health research. In 2004, Dr. Riley was elected fellow of the American Academy of Microbiology, and in 2014 he was appointed by the U.S. secretary of health and human services to serve as a member of the Board of Scientific Counselors to advise the Office of Infectious Diseases at the CDC. His research work includes tuberculosis, drug-resistant bacterial infections, and infectious diseases of urban slums. He has research collaborations in Bangladesh, Brazil, China, Colombia, India, Japan, and eastern Europe.
Thomas W. Scott, Ph.D., received his Ph.D. in ecology from The Pennsylvania State University, was a postdoctoral fellow in epidemiology at the Yale School of Medicine, and was a faculty member at the University of Maryland before relocating in 1996 to the University of California, Davis, where he is a distinguished professor of epidemiology and prevention of
mosquito-transmitted disease. He aims to assess current recommendations for disease prevention, test assumptions in public health policy, and develop innovative, cost-effective, and operationally efficient concepts for prevention of mosquito-borne disease. He has worked in Latin America, Southeast Asia, and Africa, with an emphasis on longitudinal studies of dengue in Peru and Thailand.
David L. Smith, Ph.D., is a professor of global health at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. Professor Smith studied ecology and evolutionary biology at Princeton University with Professor Simon A. Levin before moving into epidemiology and global health. Professor Smith’s scientific research has been on the ecology, epidemiology, and evolution of infectious diseases. He has published extensively on the epidemiology, dynamics, and control of malaria, influenza, cholera, rabies, Staphylococcus aureus, and nosocomial pathogens; the evolution of resistance to antibiotics in nosocomial pathogens; the evolution of resistance to antimalarial drugs; malaria elimination and eradication; and the bioeconomics of infectious diseases. Professor Smith was one of the original members of the Malaria Atlas Project, which has published evidence-based global maps of Plasmodium falciparum and P. vivax. At IHME, he works closely with the geospatial team, and his interests have expanded to include robust policy interventions to reduce all causes of mortality in children under 5 years of age. A key interest has been to develop analytical tools to compare simple and abstract compartment models to exquisitely detailed individual-based models to answer, What kinds of models (or modeling processes) tend to give the most robust policy advice? This research supports the translation of the output of sophisticated Bayesian geostatistical analysis—particularly the estimates of spatial uncertainty—into usable advice about how, where, and when to distribute interventions.
Robin Wood, D.Sc., FRS, is an infectious diseases physician, an emeritus professor of medicine at the University of Cape Town, South Africa, and the director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine. He gained his medical degree at Oxford University and completed his specialist medical training at the University of Cape Town, followed by an infectious disease fellowship at Stanford University. He has published more than 450 scientific articles in the areas of HIV, infectious diseases, and tuberculosis (TB). He currently leads a multidisciplinary research team focusing on the aerobiology of TB transmission.